<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02796404</url>
  </required_header>
  <id_info>
    <org_study_id>NUUBO</org_study_id>
    <nct_id>NCT02796404</nct_id>
  </id_info>
  <brief_title>Homebased Monitoring Cardiac Rehabilitation Program</brief_title>
  <acronym>NUUBO</acronym>
  <official_title>Effectiveness of a Homebased Cardiac Rehabilitation Program of Mixed Surveillance Using NUUBO Monitoring Vest in Patients With Ischemic Heart Disease at Moderate Cardiovascular Risk</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The current state of mobile communication and technology is a tool to support home programs
      for chronic disease management, useful to facilitate access to these types of programs,
      because the investigators could obtain telematics information about the parameters, reducing
      cardiovascular risk factors and cardiovascular morbidity and mortality.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The current state of mobile communication and technology is a tool to support home programs
      for chronic disease management, useful to facilitate access to these types of programs,
      because the investigators could obtain telematics information about the parameters, reducing
      cardiovascular risk factors and cardiovascular morbidity and mortality.

      Once the patient qualifies for inclusion in the study and has signed informed consent it is
      included in a list where randomized 7 patients in the experimental group (home-based cardiac
      rehabilitation Nuubo monitoring vest) and 7 patients are assigned to traditional cardiac
      rehabilitation group.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>August 2015</start_date>
  <completion_date type="Anticipated">June 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Effectiveness measured by exercise testing and control of cardiovascular risk factors</measure>
    <time_frame>During 12 months</time_frame>
    <description>functional capacity obtained by exercise testing and control of cardiovascular risk factors.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Results of homebased cardiac rehabilitation monitoring a traditional cardiac rehabilitation program</measure>
    <time_frame>During 12 months</time_frame>
    <description>comparing the results of functional capacity measured by exercise testing and control of cardiovascular risk factors between the two groups</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adherence to these programs</measure>
    <time_frame>3, 6 and 12 months</time_frame>
    <description>see adherence to these program at 3, 6 months and a year depending on the habit of exercise and control of cardiovascular risk factors.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety to these program</measure>
    <time_frame>During 12 months</time_frame>
    <description>See the safety of home cardiac rehabilitation program of mixed surveillance compared to traditional cardiac rehabilitation program to checking the existence of adverse cardiac events.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">148</enrollment>
  <condition>Homebased Cardiac Rehabilitation Program After Ischemic Heart Disease</condition>
  <arm_group>
    <arm_group_label>Homebased cardiac rehabilitation program</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Homebased Cardiac rehabilitation program with monitoring vest and mixed surveillance.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Traditional cardiac rehabilitation</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Multidisciplinary program in a cardiac rehabilitation gym. Routine clinical practice</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Homebased cardiac rehabilitation program</intervention_name>
    <description>homebased cardiac rehabilitation program with monitoring vest Nuubo</description>
    <arm_group_label>Homebased cardiac rehabilitation program</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Traditional cardiac rehabilitation program</intervention_name>
    <description>multidisciplinary intervention in cardiac rehabilitation gym</description>
    <arm_group_label>Homebased cardiac rehabilitation program</arm_group_label>
    <arm_group_label>Traditional cardiac rehabilitation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        All of them:

          -  Age ≤ 80 years.

          -  Stable Ischemic heart disease, revascularized by angioplasty or underwent surgery by
             coronary bypass &lt;= one year from the acute episode.

          -  Good cognitive level.

          -  Ability to perform aerobic exercise tape or cycle ergometer.

          -  Understand the use of a mobile Smartphone or Tablet.

          -  Signature of informed consent.

        And at least one of the following:

          -  Ventricular dysfunction by Ejection Fraction (FE) 40 - 50%.

          -  Functional capacity 5-7 metabolic equivalents (METS).

          -  Raising the blood pressure with the effort.

        Exclusion Criteria:

          -  Presence of malignant arrhythmias such as ventricular fibrillation outside the acute
             phase of Acute myocardial infarction (AMI) (&gt; 24 h after AMI), ventricular
             tachycardia, Atrioventricular block of 2nd degree and 3rd degree, Atrial fibrilation
             (FA) in patients with Wolf Parkinson White, fibrillation or paroxysmal atrial flutter
             with response ventricular quickly and hemodynamic deterioration, premature ventricular
             contractions increases during exertion, paroxysmal supraventricular tachycardia
             uncontrolled.

          -  Previous infarcts.

          -  Hypotensive response to exercise.

          -  Myocardial Ischemia valued at exercise test.

          -  Unstable Angina.

          -  Nonrevascularizable disease.

          -  Poorly controlled hypertension baseline.

          -  Killip III and IV Killip.

          -  No collaborator.

          -  Valvular heart disease associated.

          -  Pacemaker or Implantable Cardioverter Defibrillator.

          -  Pathology of musculoskeletal, neurological or breathing that impair the ability of
             prolonged ambulation.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Raquel Bravo, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>rbravoescobar@yahoo.es</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Raquel Bravo, MD</last_name>
    <phone>34951291977</phone>
    <email>rbravoescobar@yahoo.es</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hospital Mediterráneo</name>
      <address>
        <city>Almería</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jose Francisco Chiquero, MD</last_name>
    </contact>
    <investigator>
      <last_name>Jose Francisco Chiquero, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jose Ramon Vicente, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Carlos Gómez, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Beatriz Vargas</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Cristina Vicario</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Ines Maillo</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Reina Sofía</name>
      <address>
        <city>Córdoba</city>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Angela Heredia, MD</last_name>
    </contact>
    <investigator>
      <last_name>Angela Heredia, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>José López, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Pilar Cano, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Milagros Ramos</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Hospital Universitario Virgen de la Victoria</name>
      <address>
        <city>Malaga</city>
        <zip>29010</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Gloria Luque, MD</last_name>
      <phone>34951291977</phone>
      <email>gloria.luque@fimabis.org</email>
    </contact>
    <investigator>
      <last_name>Adela Gómez, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Angel Montiel, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rafael Aguilar</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Rosa Carrasco</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Raquel Bravo, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>May 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 23, 2016</study_first_submitted>
  <study_first_submitted_qc>June 6, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 10, 2016</study_first_posted>
  <last_update_submitted>June 6, 2016</last_update_submitted>
  <last_update_submitted_qc>June 6, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 10, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>home monitoring</keyword>
  <keyword>cardiac monitoring</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

